Insider Trading Alert - CR, ACHC, BWLD, LTM And AYR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Nov. 1, 2013, 100 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $2,920.00 to $142,506,400.00.

Highlighted Stocks Traded by Insiders:

Crane Company (CR) - FREE Research Report

Perlitz Thomas J who is VP Corp Strtgy Grp Pres Cntrls at Crane Company sold 8,000 shares at $63.51 on Nov. 1, 2013. Following this transaction, the VP Corp Strtgy Grp Pres Cntrls owned 8,165 shares meaning that the stake was reduced by 49.49% with the 8,000 share transaction.

The shares most recently traded at $63.96, up $0.45, or 0.7% since the insider transaction. Historical insider transactions for Crane Company go as follows:

  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 26,201

The average volume for Crane Company has been 294,700 shares per day over the past 30 days. Crane Company has a market cap of $3.7 billion and is part of the industrial goods sector and industrial industry. Shares are up 37.21% year to date as of the close of trading on Friday.

Crane Co. manufactures and sells engineered industrial products in the United States and internationally. The company operates in five segments: Aerospace & Electronics, Engineered Materials, Merchandising Systems, Fluid Handling, and Controls. The stock currently has a dividend yield of 1.89%. The company has a P/E ratio of 17.3. Currently there are 5 analysts that rate Crane Company a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CR - FREE

TheStreet Quant Ratings rates Crane Company as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, largely solid financial position with reasonable debt levels by most measures, notable return on equity and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Crane Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Acadia Healthcare Company (ACHC) - FREE Research Report

Carter Norman King III who is 10% Owner at Acadia Healthcare Company sold 29,600 shares at $42.20 on Nov. 1, 2013. Following this transaction, the 10% Owner owned 90,896 shares meaning that the stake was reduced by 24.57% with the 29,600 share transaction.

Prince Karen Marie who is 10% Owner at Acadia Healthcare Company sold 30,000 shares at $42.10 on Nov. 1, 2013. Following this transaction, the 10% Owner owned 38,326 shares meaning that the stake was reduced by 43.91% with the 30,000 share transaction.

The shares most recently traded at $43.02, up $0.92, or 2.15% since the insider transaction. Historical insider transactions for Acadia Healthcare Company go as follows:

  • 4-Week # shares sold: 40,400
  • 12-Week # shares sold: 40,400
  • 24-Week # shares sold: 153,400

The average volume for Acadia Healthcare Company has been 215,300 shares per day over the past 30 days. Acadia Healthcare Company has a market cap of $2.2 billion and is part of the health care sector and health services industry. Shares are up 85.94% year to date as of the close of trading on Friday.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, and substance abuse facilities in the United States. The company has a P/E ratio of 61.1. Currently there are 10 analysts that rate Acadia Healthcare Company a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACHC - FREE

TheStreet Quant Ratings rates Acadia Healthcare Company as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, premium valuation and poor profit margins. Get the full Acadia Healthcare Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Buffalo Wild Wings (BWLD) - FREE Research Report

Mack Warren E who is Director at Buffalo Wild Wings sold 1,000 shares at $140.85 on Nov. 1, 2013. Following this transaction, the Director owned 19,823 shares meaning that the stake was reduced by 4.8% with the 1,000 share transaction.

The shares most recently traded at $144.16, up $3.31, or 2.3% since the insider transaction. Historical insider transactions for Buffalo Wild Wings go as follows:

  • 4-Week # shares sold: 4,000
  • 12-Week # shares sold: 13,000
  • 24-Week # shares sold: 37,629

The average volume for Buffalo Wild Wings has been 314,000 shares per day over the past 30 days. Buffalo Wild Wings has a market cap of $2.7 billion and is part of the services sector and leisure industry. Shares are up 95.8% year to date as of the close of trading on Friday.

Buffalo Wild Wings, Inc. engages in the ownership, operation, and franchise of restaurants primarily in the United States. It offers chicken and various food and beverage items, as well as serves bottled beers, wines, and liquor. The company has a P/E ratio of 39.8. Currently there are 8 analysts that rate Buffalo Wild Wings a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BWLD - FREE

TheStreet Quant Ratings rates Buffalo Wild Wings as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Buffalo Wild Wings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Life Time Fitness (LTM) - FREE Research Report

Eugster Jack W who is Director at Life Time Fitness bought 2,000 shares at $46.34 on Nov. 1, 2013. Following this transaction, the Director owned 25,175 shares meaning that the stake was reduced by 8.63% with the 2,000 share transaction.

The shares most recently traded at $46.69, up $0.35, or 0.76% since the insider transaction. Historical insider transactions for Life Time Fitness go as follows:

  • 12-Week # shares sold: 40,865
  • 24-Week # shares sold: 143,265

The average volume for Life Time Fitness has been 300,700 shares per day over the past 30 days. Life Time Fitness has a market cap of $1.9 billion and is part of the services sector and leisure industry. Shares are down 8.29% year to date as of the close of trading on Friday.

Life Time Fitness, Inc. designs, builds, and operates sports and athletic, professional fitness, family recreation, and spa centers. The company has a P/E ratio of 15.9. Currently there are 6 analysts that rate Life Time Fitness a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LTM - FREE

TheStreet Quant Ratings rates Life Time Fitness as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, reasonable valuation levels, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Life Time Fitness Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Aircastle (AYR) - FREE Research Report

Marubeni Corp /Fi who is Director at Aircastle bought 30,000 shares at $18.96 on Nov. 1, 2013. Following this transaction, the Director owned 14.4 million shares meaning that the stake was reduced by 0.21% with the 30,000 share transaction.

The shares most recently traded at $18.96, up $0.00, or 0.02% since the insider transaction. Historical insider transactions for Aircastle go as follows:

  • 12-Week # shares sold: 26,600
  • 24-Week # shares sold: 26,600

The average volume for Aircastle has been 564,500 shares per day over the past 30 days. Aircastle has a market cap of $1.5 billion and is part of the services sector and diversified services industry. Shares are up 50.48% year to date as of the close of trading on Friday.

Aircastle Limited engages in the acquisition, lease, and sale of commercial jet aircraft to passenger and cargo airlines worldwide. The company also makes investments in various aviation assets, including debt investments secured by commercial jet aircraft. The stock currently has a dividend yield of 4.24%. The company has a P/E ratio of 117.9. Currently there are 3 analysts that rate Aircastle a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AYR - FREE

TheStreet Quant Ratings rates Aircastle as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Aircastle Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists